New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
COVID-19 cytokine storms may prevent a durable immune response

COVID-19 cytokine storms may prevent a durable immune response

by Rachel Leeson,Massachusetts General HospitalCredit: CC0 Public DomainShiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical Schoo
Public Health & Prevention April 12,2024
COVID-19 cytokine storms may prevent a durable immune response

COVID-19 cytokine storms may prevent a durable immune response

by Rachel Leeson,Massachusetts General HospitalCredit: CC0 Public DomainShiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical Schoo
Public Health & Prevention April 12,2024
Antibodies elicited by COVID-19 vaccination effective against delta variant

Antibodies elicited by COVID-19 vaccination effective against delta variant

by Tamara Bhandari,Washington University School of Medicine in St. LouisCherry Grimmett, a BJC HealthCare security officer, receives her first dose of the Pfizer COVID-19 vaccine in December 202
Public Health & Prevention April 12,2024
Antibodies elicited by COVID-19 vaccination effective against delta variant

Antibodies elicited by COVID-19 vaccination effective against delta variant

by Tamara Bhandari,Washington University School of Medicine in St. LouisCherry Grimmett, a BJC HealthCare security officer, receives her first dose of the Pfizer COVID-19 vaccine in December 202
Public Health & Prevention April 12,2024
T-cell abnormalities in severe COVID-19 cases

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed
Public Health & Prevention April 12,2024
T-cell abnormalities in severe COVID-19 cases

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed
Public Health & Prevention April 12,2024
COVID-19 vaccine responses to be studied in people with immune deficits

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe
Public Health & Prevention April 12,2024
COVID-19 vaccine responses to be studied in people with immune deficits

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe
Public Health & Prevention April 12,2024
CRISPR treatment slows swelling in hereditary angioedema patients

CRISPR treatment slows swelling in hereditary angioedema patients

by American College of Allergy, Asthma, and ImmunologyCredit: James atmos, CC BY-SA 3.0, via Wikimedia CommonsHereditary angioedema (HAE) is a rare, genetic disorder characterized by severe
Breakthroughs April 12,2024
CRISPR treatment slows swelling in hereditary angioedema patients

CRISPR treatment slows swelling in hereditary angioedema patients

by American College of Allergy, Asthma, and ImmunologyCredit: James atmos, CC BY-SA 3.0, via Wikimedia CommonsHereditary angioedema (HAE) is a rare, genetic disorder characterized by severe
Breakthroughs April 12,2024
Does the COVID-19 cytokine storm exist?

Does the COVID-19 cytokine storm exist?

by Radboud UniversityCredit: CC0 Public DomainInflammatory proteins, also known as cytokines, play a crucial role in the immune response. If this immune response is too strong, a phenomenon known
Public Health & Prevention April 12,2024
Does the COVID-19 cytokine storm exist?

Does the COVID-19 cytokine storm exist?

by Radboud UniversityCredit: CC0 Public DomainInflammatory proteins, also known as cytokines, play a crucial role in the immune response. If this immune response is too strong, a phenomenon known
Public Health & Prevention April 12,2024
CPAP improves asthma control, QoL for adults with asthma, OSA

CPAP improves asthma control, QoL for adults with asthma, OSA

(HealthDay)—For adults with asthma and obstructive sleep apnea syndrome (OSAS), continuous positive airway pressure (CPAP) is associated with improved asthma control, quality of life, and lung functio
Pulmonology April 12,2024
CPAP improves asthma control, QoL for adults with asthma, OSA

CPAP improves asthma control, QoL for adults with asthma, OSA

(HealthDay)—For adults with asthma and obstructive sleep apnea syndrome (OSAS), continuous positive airway pressure (CPAP) is associated with improved asthma control, quality of life, and lung functio
Pulmonology April 12,2024
Loss of smell following COVID linked to a person's immune reaction to the infection

Loss of smell following COVID linked to a person's immune reaction to the infection

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers from Columbia University Irving Medical Center, the University of Pennsylvania, the National Institute of Alcohol Ab
Public Health & Prevention April 12,2024
Loss of smell following COVID linked to a person's immune reaction to the infection

Loss of smell following COVID linked to a person's immune reaction to the infection

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers from Columbia University Irving Medical Center, the University of Pennsylvania, the National Institute of Alcohol Ab
Public Health & Prevention April 12,2024
COVID vaccine induces robust T cell responses in blood cancer patients

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h
Public Health & Prevention April 12,2024
COVID vaccine induces robust T cell responses in blood cancer patients

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h
Public Health & Prevention April 12,2024
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-
Oncology April 12,2024
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-
Oncology April 12,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com